Recombinant Sars-Cov-2 (COVID-19/2019-nCov) S1+S2 ECD Protein
|Amount :||100 µg|
|Purification :||>97% by SDS-PAGE.|
|Content :||Supplied as a 0.22 µm filtered solution in PBS, pH 7.4.|
|Storage condition :||This product is stable at ≤ ‑70°C for up to 6 months from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.|
|AA sequence :||Tag 6×His tag at the C-terminus. (Val11-Gln1208)|
|Gene ID :||43740568|
|Alternative Name :||cov spike Protein, 2019-nCoV;ncov spike Protein, 2019-nCoV;coronavirus spike Protein, 2019-nCoV;S glycoprotein,COVID-19;S protein;Spike glycoprotein|
Source: HEK293 cells.
Endotoxin < 0.1 EU/µg of the protein by LAL method.
Recombinant 2019-nCoV S1+S2 ECD Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Val11-Gln1208) of 2019-ncov S1+S2 ECD (Accession #YP_009724390.1) fused with an 6×His tag at the C-terminus.
Reconstitution: Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.